Nissha Co., Ltd.

Total investments

5

Average round size

5B

Portfolio companies

5

Rounds per year

0.07

Areas of investment
BiotechnologyInformation TechnologyInformation ServicesHealth CareManufacturingMedicalNeuroscienceNewsCryptocurrencyAndroid

Summary

Nissha Co., Ltd. appeared to be the Corporate Investor, which was created in 1946. The company was established in North America in United States. The main department of described Corporate Investor is located in the Geneva.

The usual things for fund are deals in the range of more than 100 millions dollars. The fund is constantly included in less than 2 deals per year. Opposing the other organizations, this Nissha Co., Ltd. works on 4 percentage points more the average amount of lead investments. The high activity for fund was in 2017.

Among the most popular portfolio startups of the fund, we may highlight Sky Medical Technology, C3Nano. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most popular fund investment industries, there are Software, Printing. The fund has specific favorite in a number of founders of portfolio startups.

The standard case for the fund is to invest in rounds with 4 partakers. Despite the Nissha Co., Ltd., startups are often financed by GSR Ventures, Phoenix Venture Partners LLC, Juno Capital Partners. The meaningful sponsors for the fund in investment in the same round are Sony, Innovation Network Corporation of Japan, Xinjiang Guoli Minsheng Equity Investment. In the next rounds fund is usually obtained by Barvest Ventures.

Show more

Investments analytics

Analytics

Total investments
5
Lead investments
0
Rounds per year
0.07
Investments by industry
  • Health Care (2)
  • Biotechnology (2)
  • Manufacturing (2)
  • Neuroscience (1)
  • Medical (1)
  • Show 12 more
Investments by region
  • Israel (1)
  • Japan (2)
  • United States (1)
  • United Kingdom (1)
Peak activity year
2017
Number of Unicorns
1
Number of Decacorns
1
Number of Minotaurs
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
11
Avg. valuation at time of investment
300M
Group Appearance index
1.00
Strategy success index
0.60

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Nanotis 15 Apr 2021 Biotechnology, Health Care, Health Diagnostics, Nursing and Residential Care Seed 182K Chiyoda, Japan
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.